- The U.S. Food and Drug Administration (FDA) recently warned about a shortage of albuterol, a medication used to aid patients with breathing conditions, including asthma, after its manufacturer halted production.
- “FDA is working to address a shortage of a particular form of albuterol … a medication that is used to treat breathing conditions. It is important to note that this shortage does not impact albuterol inhalers for personal use,” a post from the FDA read.
- The FDA flagged the aerosolized form of albuterol that is used in hospitals and nursing homes.
